Ginkgo Bioworks
DNA
DNA
314 hedge funds and large institutions have $1.51B invested in Ginkgo Bioworks in 2023 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 102 increasing their positions, 81 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
4% less first-time investments, than exits
New positions opened: 45 | Existing positions closed: 47
2% less funds holding
Funds holding: 320 → 314 (-6)
10% less capital invested
Capital invested by funds: $1.68B → $1.51B (-$166M)
Holders
314
Holding in Top 10
3
Calls
$4.29M
Puts
$3.93M
Top Buyers
| 1 | +$127M | |
| 2 | +$32.3M | |
| 3 | +$14.8M | |
| 4 |
Morgan Stanley
New York
|
+$12.6M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$10.7M |
Top Sellers
| 1 | -$6.96M | |
| 2 | -$2.96M | |
| 3 | -$2.41M | |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$2.07M |
| 5 |
Goldman Sachs
New York
|
-$2M |